These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11720611)

  • 21. L-Carnitine: therapeutic applications of a conditionally-essential amino acid.
    Kelly GS
    Altern Med Rev; 1998 Oct; 3(5):345-60. PubMed ID: 9804680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.
    Herbaczyńska-Cedro K
    J Physiol Pharmacol; 1999 Dec; 50(4):653-60. PubMed ID: 10639015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.
    Perna AF; Acanfora F; Satta E; Lombardi C; Capasso R; Ingrosso D; De Santo NG
    J Nephrol; 2007; 20(1):63-5. PubMed ID: 17347975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
    Riccioni C; Sarcinella R; Palermo G; Izzo A; Liguori M; Koverech A; Messano M; Virmani A
    Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial function, energy provision, and carnitine deficiency in experimental uremia.
    Reddy V; Bhandari S; Seymour AM
    J Am Soc Nephrol; 2007 Jan; 18(1):84-92. PubMed ID: 17182887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic cardiology: an integrative strategy in the treatment of congestive heart failure.
    Sinatra ST
    Altern Ther Health Med; 2009; 15(3):44-52. PubMed ID: 19472864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of ischemia in paced rat Langendorff hearts by supply of L-carnitine: role of endogenous long-chain acylcarnitine.
    Hulsmann WC; Peschechera A; Serafini F; Ferrari LE
    Mol Cell Biochem; 1996 Mar; 156(1):87-91. PubMed ID: 8709980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: different participation of NO and COX-products.
    Bueno R; Alvarez de Sotomayor M; Perez-Guerrero C; Gomez-Amores L; Vazquez CM; Herrera MD
    Life Sci; 2005 Sep; 77(17):2082-97. PubMed ID: 15958269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure.
    Mancini M; Rengo F; Lingetti M; Sorrentino GP; Nolfe G
    Arzneimittelforschung; 1992 Sep; 42(9):1101-4. PubMed ID: 1445476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report.
    Gasbarrini G; Mingrone G; Giancaterini A; De Gaetano A; Scarfone A; Capristo E; Calvani M; Caso V; Greco AV
    Hepatogastroenterology; 2003; 50(53):1385-9. PubMed ID: 14571743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure.
    Ferrari R; De Giuli F
    J Card Fail; 1997 Sep; 3(3):217-24. PubMed ID: 9330130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carnitine acyltransferases and their influence on CoA pools in health and disease.
    Ramsay RR; Zammit VA
    Mol Aspects Med; 2004; 25(5-6):475-93. PubMed ID: 15363637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
    Mingorance C; Gonzalez del Pozo M; Dolores Herrera M; Alvarez de Sotomayor M
    Br J Nutr; 2009 Oct; 102(8):1145-53. PubMed ID: 19545458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of carnitine esters in brain neuropathology.
    Virmani A; Binienda Z
    Mol Aspects Med; 2004; 25(5-6):533-49. PubMed ID: 15363640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physiological functions of carnitine and carnitine transporters in the central nervous system].
    Inazu M; Matsumiya T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):113-20. PubMed ID: 18646596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 8-day therapy with propionyl-L-carnitine on muscular and subcutaneous blood flow of the lower limbs in patients with peripheral arterial disease.
    Bolognesi M; Amodio P; Merkel C; Godi L; Gatta A
    Clin Physiol; 1995 Sep; 15(5):417-23. PubMed ID: 8846662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidant activity of propionyl-L-carnitine in liver and heart of spontaneously hypertensive rats.
    Gómez-Amores L; Mate A; Revilla E; Santa-María C; Vázquez CM
    Life Sci; 2006 Mar; 78(17):1945-52. PubMed ID: 16263137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stereopharmacology of carnitine].
    Spasov AA; IIezhitsa IN
    Ross Fiziol Zh Im I M Sechenova; 2005 Dec; 91(12):1469-80. PubMed ID: 16493928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of carnitine therapy in kidney dialysis patients and effects on cardiac function from human and animal studies.
    Molyneux R; Seymour AM; Bhandari S
    Curr Drug Targets; 2012 Feb; 13(2):285-93. PubMed ID: 22204325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis therapy in ischemic disease.
    Silvestre JS; Lévy BI
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):189-96. PubMed ID: 11998334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.